Free Trial
LON:AGY

Allergy Therapeutics (AGY) Share Price, News & Analysis

Allergy Therapeutics logo
GBX 8 -0.25 (-3.03%)
As of 12:06 PM Eastern

About Allergy Therapeutics Stock (LON:AGY)

Key Stats

Today's Range
7.60
8.30
50-Day Range
6.50
8.25
52-Week Range
3.80
8.30
Volume
575,978 shs
Average Volume
420,285 shs
Market Capitalization
£393.21 million
P/E Ratio
N/A
Dividend Yield
8.33%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive AGY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Allergy Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

AGY Stock News Headlines

Allergy Therapeutics plc (AGY.L) - Yahoo Finance
A grave, grave error.
I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.
Allergy Therapeutics Seeks Approval for Grass Allergy Treatment
Allergy Therapeutics Unveils Incentive Plans and Share Repurchase
Allergy Therapeutics Shows Financial Turnaround and Clinical Progress
Allergy Therapeutics Sees Growth and Strategic Advances
See More Headlines

AGY Stock Analysis - Frequently Asked Questions

Allergy Therapeutics' stock was trading at GBX 6.53 at the beginning of the year. Since then, AGY stock has increased by 22.6% and is now trading at GBX 8.

Allergy Therapeutics plc (LON:AGY) announced its quarterly earnings results on Monday, March, 31st. The company reported ($0.23) earnings per share for the quarter. Allergy Therapeutics had a negative trailing twelve-month return on equity of 266.59% and a negative net margin of 72.86%.

Shares of AGY stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

Based on aggregate information from My MarketBeat watchlists, some other companies that Allergy Therapeutics investors own include (RLYP) (RLYP), Royalty Pharma (RPRX), genedrive (GDR), Intel (INTC), IQE (IQE), AstraZeneca (AZN) and Babcock International Group (BAB).

Company Calendar

Last Earnings
3/31/2025
Today
7/14/2025

Industry, Sector and Symbol

Stock Exchange
LON
Sector
Medical
Industry
Drug Manufacturers - Specialty & Generic
Sub-Industry
N/A
Current Symbol
LON:AGY
CIK
N/A
Fax
N/A
Employees
612
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
GBX (1.04)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
-30.7
Net Income
-£52.59 million
Net Margins
-72.86%
Pretax Margin
N/A
Return on Equity
-266.59%
Return on Assets
-34.76%

Debt

Debt-to-Equity Ratio
835.48
Current Ratio
1.63
Quick Ratio
1.48

Sales & Book Value

Annual Sales
£72.18 million
Price / Sales
5.45
Cash Flow
GBX 2.19 per share
Price / Cash Flow
3.66
Book Value
GBX 0.10 per share
Price / Book
81.07

Miscellaneous

Outstanding Shares
4,915,066,273
Free Float
N/A
Market Cap
£393.21 million
Optionable
Not Optionable
Beta
1.40
A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for July 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (LON:AGY) was last updated on 7/14/2025 by MarketBeat.com Staff
From Our Partners